ASCLS eNewsBytes

• Elusive Tularemia Proteins Reveal Possible Treatment Target in Rare Tick-Borne Disease May 12, 2026
  Tularemia is a rare but highly infectious disease caused by the bacterium Francisella tularensis, which can evade immune defenses. Symptoms include fever, swollen lymph nodes and potentially pneumonia.
• Hidden Driver of Stem Cell Aging Discovered May 12, 2026
  A novel study reveals that MLKL, a protein linked to cell death, plays a significant role in stem cell aging influenced by cellular stress. This discovery opens potential therapeutic pathways to combat age-related decline.
• HIV Increases Mortality Risk in Patients With Hepatocellular Carcinoma May 12, 2026
  Individuals with HIV and hepatocellular carcinoma experience increased all-cause and cancer-specific mortality, underscoring the necessity for enhanced prevention, screening and diagnostic strategies for this aging population.
• FDA Approves First Nonantipsychotic Treatment for Agitation Associated With Alzheimer Disease May 12, 2026
  The FDA has approved Auvelity for treating agitation associated with Alzheimer's disease, representing a notable change in the management of this challenging neuropsychiatric symptom.
• AI Pathology Framework Can Enable a Deeper Understanding of Cancer May 12, 2026
  The digital transformation of pathology is enhancing cancer diagnosis by utilizing advanced artificial intelligence techniques. These methods go beyond automation, allowing the extraction of hidden biological information from histological tissue sections, which aids in a more profound comprehension of tumor diseases.